Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
‘When the dealin’s done’ — Congressional Hits and Misses
Lawmakers buck calls to defund low-income heating program
DOJ drops investigation into Fed’s Powell
Photos of the week | April 17-23, 2026
Lutnick urges boost for trade enforcement at BIS
Year-round E15 supporters hopeful for amendment to farm bill
